Study Reveals Financial Hardship for Cancer Survivors Due to High-Cost Immunotherapies, Especially Among Blood Cancer Patients

A study published today in the Journal of Cancer Survivorship found that cancer survivors receiving high-cost immunotherapy treatments were more likely to face financial hardship, leading to increased instances of being unable to afford care and taking fewer medications due to cost.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks